Prostate Cancer — Telomere Associated Variables (TAVs) in Prostate Cancer
Citation(s)
Breslow RA, Shay JW, Gazdar AF, Srivastava S Telomerase and early detection of cancer: a National Cancer Institute workshop. J Natl Cancer Inst. 1997 May 7;89(9):618-23. doi: 10.1093/jnci/89.9.618. No abstract available.
Hanahan D, Weinberg RA The hallmarks of cancer. Cell. 2000 Jan 7;100(1):57-70. doi: 10.1016/s0092-8674(00)81683-9. No abstract available.
Heaphy CM, Meeker AK The potential utility of telomere-related markers for cancer diagnosis. J Cell Mol Med. 2011 Jun;15(6):1227-38. doi: 10.1111/j.1582-4934.2011.01284.x.
Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. Eur Urol. 2016 Jul;70(1):106-119. doi: 10.1016/j.eururo.2016.02.028. Epub 2016 Mar 17.
Wright WE, Shay JW Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med. 2000 Aug;6(8):849-51. doi: 10.1038/78592.
Measurement of Telomere Associated Variables (TAVs) for Diagnostic Purposes in Prostate Cancer
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
